ACAD
Price
$25.69
Change
-$0.30 (-1.15%)
Updated
Sep 2, 04:59 PM (EDT)
Capitalization
4.38B
70 days until earnings call
RXRX
Price
$4.67
Change
-$0.04 (-0.85%)
Updated
Sep 2, 04:59 PM (EDT)
Capitalization
2.04B
64 days until earnings call
Interact to see
Advertisement

ACAD vs RXRX

Header iconACAD vs RXRX Comparison
Open Charts ACAD vs RXRXBanner chart's image
ACADIA Pharmaceuticals
Price$25.69
Change-$0.30 (-1.15%)
Volume$39.3K
Capitalization4.38B
Recursion Pharmaceuticals
Price$4.67
Change-$0.04 (-0.85%)
Volume$52.12K
Capitalization2.04B
ACAD vs RXRX Comparison Chart in %
Loading...
ACAD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACAD vs. RXRX commentary
Sep 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACAD is a StrongBuy and RXRX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 03, 2025
Stock price -- (ACAD: $25.99 vs. RXRX: $4.70)
Brand notoriety: ACAD and RXRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACAD: 70% vs. RXRX: 63%
Market capitalization -- ACAD: $4.38B vs. RXRX: $2.04B
ACAD [@Biotechnology] is valued at $4.38B. RXRX’s [@Biotechnology] market capitalization is $2.04B. The market cap for tickers in the [@Biotechnology] industry ranges from $100.25B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACAD’s FA Score shows that 1 FA rating(s) are green whileRXRX’s FA Score has 1 green FA rating(s).

  • ACAD’s FA Score: 1 green, 4 red.
  • RXRX’s FA Score: 1 green, 4 red.
According to our system of comparison, ACAD is a better buy in the long-term than RXRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACAD’s TA Score shows that 3 TA indicator(s) are bullish while RXRX’s TA Score has 4 bullish TA indicator(s).

  • ACAD’s TA Score: 3 bullish, 4 bearish.
  • RXRX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ACAD is a better buy in the short-term than RXRX.

Price Growth

ACAD (@Biotechnology) experienced а +0.97% price change this week, while RXRX (@Biotechnology) price change was -4.86% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.83%. For the same industry, the average monthly price growth was +22.37%, and the average quarterly price growth was +32.94%.

Reported Earning Dates

ACAD is expected to report earnings on Nov 11, 2025.

RXRX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+6.83% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACAD($4.39B) has a higher market cap than RXRX($2.04B). ACAD YTD gains are higher at: 41.635 vs. RXRX (-30.473). ACAD has higher annual earnings (EBITDA): 104M vs. RXRX (-583.64M). ACAD has more cash in the bank: 762M vs. RXRX (525M). ACAD has less debt than RXRX: ACAD (56.3M) vs RXRX (88.1M). ACAD has higher revenues than RXRX: ACAD (1.02B) vs RXRX (64.5M).
ACADRXRXACAD / RXRX
Capitalization4.39B2.04B215%
EBITDA104M-583.64M-18%
Gain YTD41.635-30.473-137%
P/E Ratio19.54N/A-
Revenue1.02B64.5M1,580%
Total Cash762M525M145%
Total Debt56.3M88.1M64%
FUNDAMENTALS RATINGS
ACAD: Fundamental Ratings
ACAD
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
29
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACADRXRX
RSI
ODDS (%)
Bearish Trend 5 days ago
61%
Bullish Trend 5 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 5 days ago
66%
Bullish Trend 5 days ago
83%
Momentum
ODDS (%)
N/A
Bearish Trend 5 days ago
89%
MACD
ODDS (%)
Bullish Trend 5 days ago
73%
Bearish Trend 5 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 5 days ago
76%
Bearish Trend 5 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
79%
Bearish Trend 5 days ago
86%
Advances
ODDS (%)
Bullish Trend 7 days ago
74%
Bullish Trend 12 days ago
85%
Declines
ODDS (%)
Bearish Trend 5 days ago
69%
Bearish Trend 5 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
64%
Bullish Trend 5 days ago
88%
Aroon
ODDS (%)
Bullish Trend 5 days ago
78%
Bearish Trend 5 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
ACAD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
UIISX18.980.02
+0.11%
Victory Income Stock Institutional
TIBOX31.42-0.02
-0.06%
Thornburg Investment Income Builder R6
AWPCX17.06-0.11
-0.64%
AB Sustainable Intl Thematic C
LMGEX20.68-0.17
-0.82%
Franklin International Equity C
WSACX29.85-0.29
-0.96%
Wellington Shields All-Cap Instl

ACAD and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACAD has been loosely correlated with AURA. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if ACAD jumps, then AURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACAD
1D Price
Change %
ACAD100%
-0.91%
AURA - ACAD
40%
Loosely correlated
-2.64%
CRSP - ACAD
40%
Loosely correlated
-2.30%
STTK - ACAD
40%
Loosely correlated
-1.22%
RXRX - ACAD
38%
Loosely correlated
-3.39%
SYRE - ACAD
38%
Loosely correlated
-1.38%
More

RXRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RXRX has been closely correlated with CRSP. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if RXRX jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RXRX
1D Price
Change %
RXRX100%
-3.39%
CRSP - RXRX
68%
Closely correlated
-2.30%
BEAM - RXRX
63%
Loosely correlated
-2.91%
ABSI - RXRX
62%
Loosely correlated
-3.24%
ABCL - RXRX
58%
Loosely correlated
-2.79%
NTLA - RXRX
55%
Loosely correlated
-2.11%
More